The U.S. Federal Trade Commission (FTC) today said it secured $12 million in a settlement with Edwards (NYSE:EW) and Genesis ...

The artificial heart valve maker will settle allegations it deliberately structured its deal to acquire JC Medical to ...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced that the U.S. District Court for the District of Columbia has granted the motion from the U.S. Federal Trade Commission ...

Regulators in their complaint alleged the companies structured the transaction value of Edwards's July 2024 purchase of Genesis-unit JC Medical -- which was developing an aortic-v ...

Aug 6 (Reuters) - The U.S. Federal Trade Commission has sued to block Edwards Lifesciences Corp's (EW.N), opens new tab acquisition of JenaValve Technology Inc, saying in a lawsuit filed in Washington ...

The Federal Trade Commission (FTC) has moved to block Edwards Lifesciences’ purchase of JenaValve Technology and its transcatheter heart valve implant for treating aortic regurgitation, which is ...

Edwards Lifesciences unloaded its critical care business in a $4.2 billion sale to BD in June, and the structural heart company has been on a spending spree ever since. Most recently, Edwards bought ...

Edwards Lifesciences said it no longer plans to acquire JenaValve after the Federal Trade Commission moved to block the deal. A Washington, D.C., district court granted a motion from the FTC for an ...

Add Yahoo as a preferred source to see more of our stories on Google. JenaValve has received premarket approval from the Food and Drug Administration for its transcatheter heart valve to treat ...